Compare BioNTech SE - ADR (BNTX) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs 10X Genomics Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: BioNTech SE - ADR is far larger — about 3.1× 10X Genomics Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | TXG | |
|---|---|---|
Market Cap | $23.31B | $7.61B |
Sector | Health | Health |
52-Week High | $119.34 | $58.57 |
52-Week Low | $83.89 | $11.34 |
Enterprise Value | $6.60B | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
